Reported AEs were evaluated on two trials, Children’s Oncology Group AAML03P1 and AAML0531 arm B, with identical chemotherapy regimens but with different toxicity reporting requirements. Chart review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results